Time course of changes in the subpopulation composition of peripheral blood lymphocytes in the pregravid preparation of women with recurrent miscarriage

1. Saraswat L., Bhattacharya S., Maheshwari A., Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG. 2010; 117(3): 245-57.

2. van Oppenraaij R.H., Jauniaux E., Christiansen O.B., Horcajadas J.A., Farquharson R.G., Exalto N.; ESHRE Special Interest Group for Early Pregnancy (SIGEP). Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Hum. Reprod. Update. 2009; 15(4):409-21.

3. Sidelnikova V.M., Sukhikh G.T. Recurrent pregnancy loss: Guidelines for clinicians. Moscow: MIA; 2011. 516p. (in Russian)

4. Carp Howard J.A., ed. Recurrent pregnancy loss: causes, controversies and treatment. Informa UK ltd.; 2007. 290p.

5. Chong P.J., Matzner W.L., Ching W.T. Benefit of leukocyte immunizations? Fertil. Steril. 1993; 59(1): 247-9.

6. Chong P.J., Matzner W.L., Ching W.T. Controversy about immunotherapy. Fertil. Steril. 1993; 59(5): 1138-9.

7. Sukhikh G.T., Vanko L.V. Immunology of pregnancy. Moscow: Izdatel’stvo RAMN; 2003. 400p. (in Russian)

8. Posiseeva L.V., Malyshkina A.I., Boiko E.L., Sotnikova N.Y., Peretyatko L.P., Fetisova I.N. Reabilitation of the reproductive health of married couples with recurrent pregnancy loss. Ivanovo: JSC Ivanovo; 2008. 240p. (in Russian)

9. Petrosyan L.A. Optimization of limphocytotherapy for treatment of the 1st trimester recurrent pregnancy losses. Avtoreferat diss. kand. med. sciences. Moscow; 2009. 24p. (in Russian)

10. Khonina N.A., Broitman E.V., Shevela E.Y., Pasman N.M., Chernykh E.R. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch. Gynecol. Obstet. 2013; 288(4): 933-7.

11. Nonaka T., Takakuwa K., Ooki I., Akashi M., Yokoo T., Kikuchi A, Tanaka K. Results of immunotherapy for patients with unexplained primary recurrent abortions--prospective non-randomized cohort study. Am. J. Reprod. Immunol. 2007; 58(6): 530-6.

12. Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am. J. Reprod Immunol. 1994; 32(3): 255.

13. Raghupathy R., Al-Mutawa E., Al-Azemi M., Makhseed M., Azizieh F., Szekeres-Bartho J. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J. Reprod. Immunol. 2009; 80(1-2): 91-9.

14. Arck P., Hansen P.J., Mulac Jericevic B., Piccinni M.P., Szekeres-Bartho J. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am. J. Reprod. Immunol. 2007; 58(3): 268-79.

15. Check J.H., Szekeres-Bartho J., O’Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am. J. Reprod. Immunol. 1996; 35(3): 277-80.

16. Ku C.W., Allen J.C. Jr., Malhotra R., Chong H.C., Tan N.S., Østbye T. et al. How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage? Gynecol. Endocrinol. 2015; 31(8): 647-51.

17. Hudić I., Stray-Pedersen B., Szekeres-Bartho J., Fatušić Z., Dizdarević-Hudić L., Tomić V. et al. Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth. J. Reprod. Immunol. 2015;109: 36-40.

18. Szekeres-Bartho J., Weill B.J., Mike G., Houssin D., Chaouat G. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol. Lett. 1989; 22(4): 259-61.

19. Sidelnikova V.M. Preparation and maintenance of pregnancy in women with recurrent pregnancy loss: manuals and clinical guidelines. Moscow: MEDpress-inform; 2011. 224p. (in Russian)

20. Chaouat G. Inflammation, NK cells and implantation: friend and foe (the good, the bad and the ugly?): replacing placental viviparity in an evolutionary perspective. J. Reprod. Immunol. 2013; 97(1): 2-13.

21. Saito S., Shima T., Nakashima A., Shiozaki A., Ito M., Sasaki Y. What is the role of regulatory T cells in the success of implantation and early pregnancy? J. Assist. Reprod. Genet. 2007; 24(9): 379-86.

22. Williams Zev. Inducing tolerance to pregnancy. N. Engl. J. Med. 2012; 367(12): 1159-61.

23. Vacca P., Cantoni C., Vitale M., Prato C., Canegallo F., Fenoglio D. et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. USA. 2010; 107(26): 11918-23.

24. Trabanelli S., Ocadlikova D., Evangelisti C., Parisi S., Curti A. Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance. Curr. Med. Chem. 2011; 18(15): 2234-9.

25. Clark D.A., Wong K., Banwatt D., Chen Z., Liu J., Lee L. et al. CD200-dependent and nonCD200-dependent pathways of NK cell suppression by human IVIG. J. Assist. Reprod. Genet. 2008; 25(2-3):67-72.

26. Clark D.A. Cell surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am. J. Reprod. Immunol. 2009; 61: 75-84.

27. Krechetova L.V., Nikolaeva M.A., Van’ko L.V., Ziganshina M.M., Golubeva E.L., Stepanova E.O., Sukhikh G.T. Optimal detection of serum antipaternal antileukocytic antibodies after injection of allogenic lymphocytes in woman with habitual abortions. Bulletin of Experimental Biology and Medicine. 2012; 153(5): 726-9.

Received 25.04.2017

Accepted 28.04.2017